Health & Medicine
-
FDA Approves Yuhan’s Lazertinib, First Korean-Developed Cancer Drug to Win Approval
South Korea, August 16, 2024 — cyberinktimes.com — Almost four years after South Korean regulators gave it the green light, Lazertinib has…
-
Axatilimab Approved For Chronic Graft Versus Host Disease Treatment
United States, August 16, 2024 — infopulsetoday.com — Axatilimab, a monoclonal antibody marketed under the brand name Niktimvo, has been approved for…
-
Polio Confirmed in Gaza Child After 25-Year Absence
The first case of polio in the Gaza Strip in 25 years has been confirmed, sparking concern among health officials. According to…
-
Lazertinib Approved in US for Non-Small Cell Lung Cancer Treatment
In August 2024, the U.S. Food and Drug Administration granted approval for lazertinib, expanding the therapeutic arsenal against non‑small cell lung cancer…
-
WHO Declares Mpox a Global Health Emergency for the Second Time as Virus Surges in Africa
Since September 2023, Central Africa has recorded more than 29,000 cases of mpox, with the death toll surpassing 800. The fatality ratio…
-
Deli Meat Outbreak in US Claims Lives and Sparks Safety Concerns
A listeriosis outbreak tied to Boar’s Head Provision Company deli meats has led to at least 10 fatalities and 60 hospitalizations across…
-
Gaza Records First Polio Case in 25 Years as UN Presses for Vaccination Pause
Gaza, July 23, 2024 — infopulsetoday.com — The Gaza Strip’s declaration of a polio epidemic on July 16, 2024, did not happen…
-
FDA Approves Eli Lilly Alzheimer’s Drug Kisunla Amid Safety Concerns
July 18, 2024 — infopulsetoday.com — The path to the FDA’s July 15 approval of donanemab was paved with controversy, clinical risk,…
-
FDA Approves Eli Lilly’s Donanemab for Early Symptomatic Alzheimer Disease
On July 15, 2024, the US Food and Drug Administration (FDA) approved donanemab, a monoclonal antibody developed by Eli Lilly and Company,…
-
Gaza Declares Polio Epidemic After Virus Found in Sewage, 25 Years After Eradication
The 2024 Gaza Strip polio epidemic, an outbreak of circulating vaccine-derived poliovirus type 2 (cVDPV2), was first discovered on July 16, 2024,…
-
Gaza Confirms First Polio Case in 25 Years After Virus Found in Sewage
In the summer of 2024, an unexpected health crisis unfolded in the Gaza Strip, marking a grim resurgence of polio – a…
-
Researchers Identify Lupus Root Cause, Potential Cure
Chicago, July 10, 2024 — infopulsetoday.com — For millions living with systemic lupus erythematosus, the disease has long felt like a life…
-
Northwestern and Brigham Scientists Identify Immune Defect in Lupus and a Possible Way to Reverse It
On July 10, 2024, a joint research team from Northwestern University Feinberg School of Medicine and Harvard Medical School released a study…
-
UK E. coli Outbreak Linked to Supermarket Sandwiches Kills One, 275 Cases Confirmed
A fatal E. coli outbreak in the United Kingdom has resulted in one death and 67 hospitalizations as of June 27, 2024.…
-
Grail spin-out from Illumina completed June 2024 after EU regulatory order
June 29, 2024 — cyberinktimes.com — On June 24, 2024, a significant development occurred in the biotechnology sector as GRAIL, Inc., a…
-
FDA Approves Imetelstat for Treating Myelodysplastic Syndromes with Anemia
In a pivotal shift for the cancer treatment landscape, the US Food and Drug Administration (FDA) granted approval on June 15, 2024,…
-
FDA Advisers Vote Against MDMA Therapy for PTSD, Citing Flawed Trial Data
On June 5, 2024, an advisory committee to the Food and Drug Administration voted that the current evidence does not support approving…
-
FDA Panel Rejects MDMA Therapy for PTSD Approval
A significant decision was made by a panel of the United States Food and Drug Administration on June 5, 2024, as they…
-
Hamilton Child Under 5 Dies of Measles, Ontario’s First Measles Death Since 1989
/ HTML. No extra text. No quotes? We can include quotes if they are from source; but we must not invent quotes.…
-
FDA Grants Accelerated Approval to Imdelltra for Extensive-Stage Small Cell Lung Cancer
The U.S. Food and Drug Administration announced in May 2024 that it has approved Tarlatamab, marketed as Imdelltra, for the treatment of…
-
FDA Approves First-in-Class Tarlatamab for Aggressive Lung Cancer
The U.S. Food and Drug Administration approved Tarlatamab on May 15, 2024, marking a significant development for patients facing extensive-stage small cell…
-
Moderna’s KRAS Cancer Vaccine Candidate Was Dropped by Merck After Phase 1 Enrollment
In the realm of cancer research, the tetravalent vaccine candidate, code-named V941 or mRNA-5671, developed by Moderna, continues to garner attention within…
-
Merck Handed Back Moderna’s KRAS Cancer Vaccine in 2022 and the Trial Ended for Business Reasons
More than two years have passed since Merck discontinued a high-profile cancer vaccine trial, yet the underlying scientific questions persist without resolution.…
-
FDA Gives Tarlatamab Full Approval for Small Cell Lung Cancer After 2024 Accelerated Nod
Tarlatamab, a groundbreaking anti-cancer medication, has been approved for medical use in the United States as of May 2024. Sold under the…
Most read
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Experimental Drug Combo Doubles One-Year Survival Rates in Pancreatic Cancer Trial
-
Factor XIa Inhibitor Asundexian Cuts Recurrent Stroke Risk Without Raising Major Bleeding
-
UCSF Scientists Eliminate Deadly Brain Tumors in Mice with B-SYNC Therapy
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Why Achieve Says Most Americans Feel Their Financial Stability is Slipping Away
-
Locking In High Yields: How Current CD Rates Offer Safe Returns Amid Shifting Economic Outlooks
-
Medicare Denies $949 Multi-Cancer Blood Test, Leaving Seniors With Full Bill Until 2029
-
India’s NPPA slashes 137 cancer drug prices by up to 96%, saving ₹3,500 crore annually
-
Inside AbbVie’s High-Stakes Neuro Portfolio and Pipeline Strategy
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992